Lioton 1000

Heparin Sodium, the active ingredient in Lioton 1000, is an anticoagulant presented as a cutaneous preparation for cutaneous use. It helps prevent clot formation in patients at risk of thrombosis. GNH USA supplies Lioton 1000 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Lioton 1000, a heparin sodium product, is employed in clinical situations that require anticoagulation to reduce clot formation.

- Deep vein thrombosis prophylaxis: helps prevent clot development in at‑risk surgical or immobilized patients. - Pulmonary embolism treatment: aids in dissolving existing clots and preventing new ones in the pulmonary arteries. - Cardiac surgery anticoagulation: maintains patency of extracorporeal circuits during procedures. - Acute coronary syndrome management: reduces the risk of further coronary artery occlusion. - Catheter‑related thrombosis prevention: minimizes clot formation around intravascular devices.

Heparin Sodium may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Minor bleeding or bruising at the application site. - Local skin irritation or erythema. - Mild thrombocytopenia. - Elevated liver enzymes. - Nausea or mild gastrointestinal discomfort.

Serious or Rare Side Effects: - Heparin‑induced thrombocytopenia (HIT) with paradoxical clotting. - Major hemorrhage, including intracranial bleeding. - Spinal or epidural hematoma. - Severe allergic reactions such as anaphylaxis. - Osteopenia with prolonged use. - Adrenal hemorrhage.

When using Lioton 1000, consider the following safety measures.

- Monitor coagulation parameters: regularly assess activated partial thromboplastin time (aPTT) or anti‑Xa levels. - Assess bleeding risk: avoid use in patients with active or uncontrolled bleeding. - Review medical history: contraindicated in individuals with known heparin‑induced thrombocytopenia. - Adjust for age and renal/hepatic function: elderly or organ‑impaired patients may require closer observation. - Caution with concomitant anticoagulants: increased bleeding potential when combined with other blood thinners. - Store at below 25°C: keep in the original packaging, protect from moisture and direct light.

Heparin Sodium can interact with several medication classes, influencing its anticoagulant effect.

Major Interactions (Avoid): - Other anticoagulants (e.g., warfarin, direct oral anticoagulants): additive bleeding risk. - Antiplatelet agents (e.g., aspirin, clopidogrel): heightened hemorrhage potential. - Thrombolytic drugs (e.g., alteplase): may cause uncontrolled bleeding. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): increase gastrointestinal bleeding. - Certain antibiotics (e.g., quinine, vancomycin): can potentiate anticoagulant effect.

Moderate Interactions (Monitor Closely): - ACE inhibitors: may enhance hypotensive effects when combined with heparin‑related bleeding. - Corticosteroids: can exacerbate gastrointestinal ulceration. - Selective serotonin reuptake inhibitors (SSRIs): modest increase in bleeding tendency. - Statins: occasional reports of increased bleeding risk. - Herbal supplements (e.g., ginkgo, garlic): may augment anticoagulant activity.